[1]
|
Sherer, T.B., Betarbet, R., Testa, C.M., Seo, B.B., Richardson, J.R., Kim, J.H., Miller, G.W., Yagi, T., Matsuno-Yagi, A. and Greenamyre, J.T. (2003) Mechanism of Toxicity in Rotenone Models of Parkinson’s Disease. Journal of Neuroscience, 23, 10756- 10764. https://doi.org/10.1523/JNEUROSCI.23-34-10756.2003
|
[2]
|
Bobela, W., Nazeeruddin, S., Knott, G., Aebischer, P. and Schneider, B.L. (2017) Modulating the Catalytic Activity of AMPK Has Neuroprotective Effects against α-Synuclein Toxicity. Molecular Neurodegeneration, 12, 80. https://doi.org/10.1186/s13024-017-0220-x
|
[3]
|
Cortes, C.J. and La Spada, A.R. (2019) TFEB Dysregulation as a Driver of Autophagy Dysfunction in Neurodegenerative Disease: Molecular Mechanisms, Cellular Pro- cesses, and Emerging Therapeutic Opportunities. Neurobiology of Disease, 122, 83- 93. https://doi.org/10.1016/j.nbd.2018.05.012
|
[4]
|
Sheehan, P. and Yue, Z. (2019) Deregulation of Autophagy and Vesicle Trafficking in Parkinson’s Disease. Neuroscience Letters, 697, 59-65. https://doi.org/10.1016/j.neulet.2018.04.013
|
[5]
|
Ma, P., Yun, J., Deng, H. and Guo, M. (2018) Atg1 Mediated Autophagy Suppresses Tissue Degeneration in pink1/parkin Mutants by Promoting Mitochondrial Fission in Drosophila. Molecular Biology of the Cell, 29, 3082-3092. https://doi.org/10.1091/mbc.E18-04-0243
|
[6]
|
Garcia-Esparcia, P., Koneti, A., Rodríguez-Oroz, M.C., Gago, B., Del Rio, J.A. and Ferrer, I. (2018) Mitochondrial Activity in the Frontal Cortex Area 8 and Angular Gyrus in Parkinson’s Disease and Parkinson’s Disease with Dementia. Brain Pathology, 28, 43-57. https://doi.org/10.1111/bpa.12474
|
[7]
|
Van Laar, V.S. and Berman, S.B. (2013) The Interplay of Neuronal Mitochondrial Dynamics and Bioenergetics: Implications for Parkinson’s Disease. Neurobiology of Disease, 51, 43-55. https://doi.org/10.1016/j.nbd.2012.05.015
|
[8]
|
Drolet, R.E., Cannon, J.R., Montero, L. and Greenamyre, J.T. (2009) Chronic Rotenone Exposure Reproduces Parkinson’s Disease Gastrointestinal Neuropathology. Neurobiology of Disease, 36, 96-102. https://doi.org/10.1016/j.nbd.2009.06.017
|
[9]
|
Pan-Montojo, F., Anichtchik, O., Dening, Y., Knels, L., Pursche, S., Jung, R., Jackson, S., Gille, G., Spillantini, M.G., Reichmann, H. and Funk, R.H. (2010) Progression of Parkinson’s Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice. PLoS ONE, 5, e8762. https://doi.org/10.1371/journal.pone.0008762
|
[10]
|
Rocha, E.M., De Miranda, B. and Sanders, L.H. (2018) Alpha-Synuclein: Pathology, Mitochondrial Dysfunction and Neuroinflammation in Parkinson’s Disease. Neurobiology of Disease, 109, 249-257. https://doi.org/10.1016/j.nbd.2017.04.004
|
[11]
|
Fan, Z., Pan, Y.T., Zhang, Z.Y., Yang, H., Yu, S.Y., Zheng, Y., et al. (2020) Systemic Activation of NLRP3 Inflammasome and Plasma α-Synuclein Levels Are Correlated with Motor Severity and Progression in Parkinson’s Disease. Journal of Neuroinflammation, 17, 11. https://doi.org/10.1186/s12974-019-1670-6
|
[12]
|
Lahooti, B., Chhibber, T., Bagchi, S., Pooja Varahachalam, S. and Jayant, R.D. (2020) Therapeutic Role of Inflammasome Inhibitors in Neurodegenerative Disorders. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2020.11.004
|
[13]
|
Malik, B.R., Maddison, D.C., Smith, G.A. and Peters, O.M. (2019) Autophagic and Endo-Lysosomal Dysfunction in Neurodegenerative Disease. Molecular Brain, 12, 100. https://doi.org/10.1186/s13041-019-0504-x
|
[14]
|
Liu, B., Sun, J., Zhang, J., Mao, W., Ma, Y., Li, S., Cheng, X. and Lv, C. (2015) Autophagy-Related Protein Expression in the Substantia Nigra and Eldepryl Intervention in Rat Models of Parkinson’s Disease. Brain Research, 1625, 180-188. https://doi.org/10.1016/j.brainres.2015.08.033
|
[15]
|
Hang, L., Thundyil, J. and Lim, K.L. (2015) Mitochondrial Dysfunction and Parkinson Disease: A Parkin-AMPK Alliance in Neuroprotection. Annals of the New York Academy of Sciences, 1350, 37-47. https://doi.org/10.1111/nyas.12820
|
[16]
|
Qin, Y., Qiu, J., Wang, P., Liu, J., Zhao, Y., Jiang, F. and Lou, H. (2020) Impaired Autophagy in Microglia Aggravates Dopaminergic Neurodegeneration by Regulating NLRP3 Inflammasome Activation in Experimental Models of Parkinson’s Disease. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2020.10.010
|
[17]
|
Prasad, E.M. and Hung, S.Y. (2020) Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease. Antioxidants (Basel), 9, 1007. https://doi.org/10.3390/antiox9101007
|
[18]
|
Blesa, J., Trigo-Damas, I., Quiroga-Varela, A. and Jackson-Lewis, V.R. (2015) Oxidative Stress and Parkinson’s Disease. Frontiers in Neuroanatomy, 9, 91. https://doi.org/10.3389/fnana.2015.00091
|
[19]
|
Dias, V., Junn, E. and Mouradian, M.M. (2013) The Role of Oxidative Stress in Parkinson’s Disease. Journal of Parkinson’s Disease, 3, 461-491. https://doi.org/10.3233/JPD-130230
|
[20]
|
Drechsel, D.A. and Patel, M. (2008) Role of Reactive Oxygen Species in the Neurotoxicity of Environmental Agents Implicated in Parkinson’s Disease. Free Radical Biology and Medicine, 44, 1873-1886. https://doi.org/10.1016/j.freeradbiomed.2008.02.008
|
[21]
|
Xiong, N., Huang, J., Zhang, Z., Zhang, Z., Xiong, J., Liu, X., et al. (2009) Stereotaxical Infusion of Rotenone: A Reliable Rodent Model for Parkinson’s Disease. PLoS ONE, 4, e7878. https://doi.org/10.1371/journal.pone.0007878
|
[22]
|
Dodiya, H.B., Forsyth, C.B., Voigt, R.M., Engen, P.A., Patel, J., Shaikh, M., et al. (2020) Chronic Stress-Induced Gut Dysfunction Exacerbates Parkinson’s Disease Phenotype and Pathology in a Rotenone-Induced Mouse Model of Parkinson’s Disease. Neurobiology of Disease, 135, Article ID: 104352. https://doi.org/10.1016/j.nbd.2018.12.012
|
[23]
|
Ferrante, R.J., Schulz, J.B., Kowall, N.W. and Beal, M.F. (1997) Systemic Administration of Rotenone Produces Selective Damage in the Striatum and Globus Pallidus, But Not in the Substantia Nigra. Brain Research, 753, 157-162. https://doi.org/10.1016/S0006-8993(97)00008-5
|
[24]
|
Horst, C.H., Schlemmer, F., de Aguiar Montenegro, N., Domingues, A.C.M., Ferreira, G.G., da Silva Ribeiro, C.Y., et al. (2018) Signature of Aberrantly Expressed microRNAs in the Striatum of Rotenone-Induced Parkinsonian Rats. Neurochemical Research, 43, 2132-2140. https://doi.org/10.1007/s11064-018-2638-0
|
[25]
|
Inden, M., Kitamura, Y., Tamaki, A., Yanagida, T., Shibaike, T., Yamamoto, A., et al. (2009) Neuroprotective Effect of the Antiparkinsonian Drug Pramipexole against Nigrostriatal Dopaminergic Degeneration in Rotenone-Treated Mice. Neurochemistry International, 55, 760-767. https://doi.org/10.1016/j.neuint.2009.07.009
|
[26]
|
Inden, M., Kitamura, Y., Abe, M., Tamaki, A., Takata, K. and Taniguchi, T. (2011) Parkinsonian Rotenone Mouse Model: Reevaluation of Long-Term Administration of Rotenone in C57BL/6 Mice. Biological and Pharmaceutical Bulletin, 34, 92-96. https://doi.org/10.1248/bpb.34.92
|
[27]
|
Sun, C., Wang, Y., Mo, M., Song, C., Wang, X., Chen, S. and Liu, Y. (2019) Minocycline Protects against Rotenone-Induced Neurotoxicity Correlating with Upregulation of Nurr1 in a Parkinson’s Disease Rat Model. BioMed Research International, 2019, Article ID: 6843265. https://doi.org/10.1155/2019/6843265
|
[28]
|
Thanalakshmi, J., Archana, R., Senthilkumar, S., Shakila, R., Pazhanivel, N. and Subhashini, S. (2020) Role of Caloric Vestibular Stimulation in Improvement of Motor Symptoms and Inhibition of Neuronal Degeneration in Rotenone Model of Parkinson’s Disease—An Experimental Study. Physiology International. https://doi.org/10.1556/2060.2020.00036
|
[29]
|
Kavuri, S. and Sivanesan, S. (2019) Evaluation of Haematological Alterations in Intraperitoneal and Oral Rotenone Induced Parkinson’s Disease Wistar Rats. International Journal of Pharmaceutical Research & Allied Sciences, 8, 1-13.
|
[30]
|
Kavuri, S., Sivanesan, S. and Rajagopalan, V. (2020) Oxidative Stress and Antioxidant Status in Rotenone Induced Rat Model of Parkinson’s Disease. International Journal of Research in Pharmaceutical Sciences, 11, 1-5. https://doi.org/10.26452/ijrps.v11i1.1776
|
[31]
|
Cannon, J.R., Tapias, V., Na, H.M., Honick, A.S., Drolet, R.E. and Greenamyre, J.T. (2009) A Highly Reproducible Rotenone Model of Parkinson’s Disease. Neurobiology of Disease, 34, 279-290. https://doi.org/10.1016/j.nbd.2009.01.016
|
[32]
|
Inden, M., Kitamura, Y., Takeuchi, H., Yanagida, T., Takata, K., Kobayashi, Y., Taniguchi, T., Yoshimoto, K., Kaneko, M., Okuma, Y., Taira, T., Ariga, H. and Shimohama, S. (2007) Neurodegeneration of Mouse Nigrostriatal Dopaminergic System Induced by Repeated Oral Administration of Rotenone Is Prevented by 4-Phenyl- butyrate, a Chemical Chaperone. Journal of Neurochemistry, 101, 1491-1504. https://doi.org/10.1111/j.1471-4159.2006.04440.x
|
[33]
|
Singh, C.K., George, J., Nihal, M., Sabat, G., Kumar, R. and Ahmad, N. (2014) Novel Downstream Molecular Targets of SIRT1 in Melanoma: A Quantitative Proteomics Approach. Oncotarget, 5, 1987-1999. https://doi.org/10.18632/oncotarget.1898
|
[34]
|
Taguchi, K., Watanabe, Y., Tsujimura, A. and Tanaka, M. (2016) Brain Region-De- pendent Differential Expression of Alpha-Synuclein. The Journal of Comparative Neurology, 524, 1236-1258. https://doi.org/10.1002/cne.23901
|
[35]
|
Liu, L., Meng, T., Wang, Q.S., Jin, H.Z., Sun, Z.Q., Jin, B., Fang, F. and Wang, H.J. (2016) Association of Beclin-1 and microRNA-30a Expression with the Severity and Treatment Response of Colorectal Cancer. Genetics and Molecular Research, 15. https://doi.org/10.4238/gmr.15027704
|
[36]
|
Kim, S.K., Sun, B., Yoon, H., Lee, J.H., Lee, G., Sohn, S.H., Kim, H., Quan, F.S., Shim, I., Ha, J., Min, B.I. and Bae, H. (2014) Expression Levels of the Hypothalamic AMPK Gene Determines the Responsiveness of the Rats to Electroacupuncture- Induced Analgesia. BMC Complementary and Alternative Medicine, 14, 211. https://doi.org/10.1186/1472-6882-14-211
|
[37]
|
Wang, K., Huang, J., Xie, W., Huang, L., Zhong, C. and Chen, Z. (2016) Beclin1 and HMGB1 Ameliorate the α-Synuclein-Mediated Autophagy Inhibition in PC12 Cells. Diagnostic Pathology, 11, 15. https://doi.org/10.1186/s13000-016-0459-5
|
[38]
|
Huang, J., Yang, J., Shen, Y., Jiang, H., Han, C., Zhang, G., Liu, L., Xu, X., Li, J., Lin, Z., Xiong, N., Zhang, Z., Xiong, J. and Wang, T. (2017) HMGB1 Mediates Autophagy Dysfunction via Perturbing Beclin1-Vps34 Complex in Dopaminergic Cell Model. Frontiers in Molecular Neuroscience, 10, 13. https://doi.org/10.3389/fnmol.2017.00013
|
[39]
|
Tasselli, M., Chaumette, T., Paillusson, S., Monnet, Y., Lafoux, A., Huchet-Cadiou, C., Aubert, P., Hunot, S., Derkinderen, P. and Neunlist, M. (2013) Effects of Oral Administration of Rotenone on Gastrointestinal Functions in Mice. Neurogastroenterology and Motility, 25, e183-e193. https://doi.org/10.1111/nmo.12070
|
[40]
|
Inden, M., Kitamura, Y., Takahashi, K., Takata, K., Ito, N., Niwa, R., et al. (2011) Protection against Dopaminergic Neurodegeneration in Parkinson’s Disease-Model Animals by a Modulator of the Oxidized form of DJ-1, a Wild-Type of Familial Parkinson’s Disease-Linked PARK7. Journal of Pharmacological Sciences, 117, 189-203. https://doi.org/10.1254/jphs.11151FP
|
[41]
|
Minnema, D.J., et al. (2014). Dietary Administration of Paraquat for 13 Weeks Does Not Result in a Loss of Dopaminergic Neurons in the Substantia Nigra of C57BL/6J Mice. Regulatory Toxicology and Pharmacology, 68, 250-258. https://doi.org/10.1016/j.yrtph.2013.12.010
|
[42]
|
Fleming, S.M., Zhu, C., Fernagut, P.O., Mehta, A., DiCarlo, C.D., Seaman, R.L.,et al. (2004) Behavioral and Immunohistochemical Effects of Chronic Intravenous and Subcutaneous Infusions of Varying Doses of Rotenone. Experimental Neurology, 187, 418-429. https://doi.org/10.1016/j.expneurol.2004.01.023
|
[43]
|
Talpade, D.J., Greene, J.G., Higgins, D.S. and Greenamyre, J.T. (2000) In Vivo Labeling of Mitochondrial Complex I (NADH: Ubiquinone Oxidoreductase) in Rat Brain Using [(3)H]dihydrorotenone. Journal of Neurochemistry, 75, 2611-2621. https://doi.org/10.1046/j.1471-4159.2000.0752611.x
|
[44]
|
Wu, F., Xu, H.D., Guan, J.J., Hou, Y.S., Gu, J.H., Zhen, X.C. and Qin, Z.H. (2015) Rotenone Impairs Autophagic Flux and Lysosomal Functions in Parkinson’s Disease. Neuroscience, 284, 900-911. https://doi.org/10.1016/j.neuroscience.2014.11.004
|
[45]
|
Spencer, B., Potkar, R., Trejo, M., Rockenstein, E., Patrick, C., Gindi, R., Adame, A., Wyss-Coray, T. and Masliah, E. (2009) Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in Alpha-Synuclein Models of Parkinson’s and Lewy Body Diseases. Journal of Neuroscience, 29, 13578-13588. https://doi.org/10.1523/JNEUROSCI.4390-09.2009
|
[46]
|
Wang, B., Abraham, N., Gao, G. and Yang, Q. (2016) Dysregulation of Authophagy and Mitochondrial Function in Parkinson’s Disease. Translational Neurodegeneration, 5, 19. https://doi.org/10.1186/s40035-016-0065-1
|
[47]
|
Singh, R. and Cuervo, A.M. (2011) Autophagy in the Cellular Energetic Balance. Cell Metabolism, 13, 495-504. https://doi.org/10.1016/j.cmet.2011.04.004
|
[48]
|
Shah, S.Z.A., Zhao, D., Hussain, T. and Yang, L. (2017) Role of the AMPK Pathway in Promoting Autophagic Flux via Modulating Mitochondrial Dynamics in Neurodegenerative Diseases: Insight into Prion Diseases. Ageing Research Reviews, 40, 51-63. https://doi.org/10.1016/j.arr.2017.09.004
|
[49]
|
Vázquez-Manrique, R.P., Farina, F., Cambon, K., Dolores Sequedo, M., Parker, A.J., Millán, J.M., Weiss, A., Déglon, N. and Neri, C. (2016) AMPK Activation Protects from Neuronal Dysfunction and Vulnerability across Nematode, Cellular and Mouse Models of Huntington’s Disease. Human Molecular Genetics, 25, 1043-1058. https://doi.org/10.1093/hmg/ddv513
|
[50]
|
Curry, D.W., Stutz, B., Andrews, Z.B. and Elsworth, J.D. (2018) Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson’s Disease. Journal of Parkinson’s Disease, 8, 161-181. https://doi.org/10.3233/JPD-171296
|
[51]
|
Wang, P., Guan, Y.F., Du, H., Zhai, Q.W., Su, D.F. and Miao, C.Y. (2012) Induction of Autophagy Contributes to the Neuroprotection of Nicotinamide Phosphoribosyltransferase in Cerebral Ischemia. Autophagy, 8, 77-87. https://doi.org/10.4161/auto.8.1.18274
|
[52]
|
Xing, S., Zhang, Y., Li, J., Zhang, J., Li, Y., Dang, C., Li, C., Fan, Y., Yu, J., Pei, Z. and Zeng, J. (2012) Beclin 1 Knockdown Inhibits Autophagic Activation and Prevents the Secondary Neurodegenerative Damage in the Ipsilateral Thalamus Following Focal Cerebral Infarction. Autophagy, 8, 63-76. https://doi.org/10.4161/auto.8.1.18217
|
[53]
|
Hardie, D.G. (2011) AMP-Activated Protein Kinase: An Energy Sensor That Regulates All Aspects of Cell Function. Genes & Development, 25, 1895-1908. https://doi.org/10.1101/gad.17420111
|
[54]
|
Williams, R. and White, H. (1986) The Greater Omentum: Its Applicability to Cancer Surgery and Cancer Therapy. Current Problems in Surgery, 23, 789-865. https://doi.org/10.1016/0011-3840(86)90007-9
|
[55]
|
Flessner, M.F., Dedrick, R.L. and Schultz, J.S. (1985) Exchange of Macromolecules between Peritoneal Cavity and Plasma. American Journal of Physics, 248, H15-H25. https://doi.org/10.1152/ajpheart.1985.248.1.H15
|
[56]
|
Mactier, R.A. and Khanna, R. (1989) Absorption of Fluid and Solutes from the Peritoneal Cavity. Theoretic and Therapeutic Implications and Applications. ASAIO Transactions, 35, 122-131. https://doi.org/10.1097/00002216-198904000-00002
|
[57]
|
Li, Y., Xue, Y., Xu, X., Wang, G., Liu, Y., Wu, H., Li, W., Wang, Y., Chen, Z., Zhang, W., Zhu, Y., Ji, W., Xu, T., Liu, L. and Chen, Q. (2019) A Mitochondrial FUNDC1/HSC70 Interaction Organizes the Proteostatic Stress Response at the Risk of Cell Morbidity. EMBO Journal, 38, pii: e98786. https://doi.org/10.15252/embj.201798786
|
[58]
|
Ruan, L., Zhou, C., Jin, E., Kucharavy, A., Zhang, Y., Wen, Z., Florens, L. and Li, R. (2017) Cytosolic Proteostasis through Importing of Misfolded Proteins into Mitochondria. Nature, 543, 443-446. https://doi.org/10.1038/nature21695
|
[59]
|
Bensemain, F., Hot, D., Ferreira, S., Dumont, J., Bombois, S., Maurage, C.A., Huot, L., Hermant, X., Levillain, E., Hubans, C., Hansmannel, F., Chapuis, J., Hauw, J.J., Schraen, S., Lemoine, Y., Buée, L., Berr, C., Mann, D., Pasquier, F., Amouyel, P. and Lambert, J.C. (2009) Evidence for Induction of the Ornithine Transcarbamylase Expression in Alzheimer’s Disease. Molecular Psychiatry, 14, 106-116. https://doi.org/10.1038/sj.mp.4002089
|
[60]
|
Hansmannel, F., Sillaire, A., Kamboh, M.I., Lendon, C., Pasquier, F., Hannequin, D., Laumet, G., Mounier, A., Ayral, A., DeKosky, S.T., Hauw, D., Berr, C., Mann, D., Amouyel, P., Campion, D. and Lambert, J. (2010) Is the Urea Cycle Involved in Alzheimer’s Disease? Journal of Alzheimer’s Disease, 21, 1013-1021. https://doi.org/10.3233/JAD-2010-100630
|
[61]
|
Xu, J., Begley, P., Church, S.J., Patassini, S., Hollywood, K.A., Jüllig, M., Curtis, M.A., Waldvogel, H.J., Faull, R.L.M., Unwin, R.D. and Cooper, G.J.S. (2016) Graded Perturbations of Metabolism in Multiple Regions of Human Brain in Alzheimer’s Disease: Snapshot of a Pervasive Metabolic disorder. Biochimica et Biophysica Acta, 1862, 1084-1092. https://doi.org/10.1016/j.bbadis.2016.03.001
|
[62]
|
Cicolini, J., Jing, Y., Waldvogel, H.J., Faull, R.L.M. and Liu, P. (2016) Urea Cycle Enzymes and Peptidylarginine Deiminase in Alzheimer’s Superior Frontal Gyrus. Alzheimer’s & Dementia, 12, 460. https://doi.org/10.1016/j.jalz.2016.06.897
|
[63]
|
Handley, R.R., Reid, S.J., Brauning, R., Maclean, P., Mears, E.R., Fourie, I., Patassini, S., Cooper, G.J.S., Rudiger, S.R., McLaughlan, C.J., Verma, P.J., Gusella, J.F., MacDonald, M.E., Waldvogel, H.J., Bawden, C.S., Faull, R.L.M. and Snell, R.G. (2017) Brain Urea Increase Is an Early Huntington’s Disease Pathogenic Event Observed in a Prodromal Transgenic Sheep Model and HD Cases. Proceedings of the National Academy of Sciences of the United States of America, 114, E11293-E11302. https://doi.org/10.1073/pnas.1711243115
|
[64]
|
Pattassini, S., Begley, P., Reid, S.J., Church, S.J., Curtis, M., Dragunow, M., Waldvogel, H.J., Unwin, R.D., Snell, R.G., Faull, R.L. and Cooper, G.J. (2015) Identification of Elevated Urea as a Severe, Ubiquitous Metabolic Defect in the Brain of Patients with Huntington’s Disease. Biochemical and Biophysical Research Communications, 468, 161-166. https://doi.org/10.1016/j.bbrc.2015.10.140
|